Share this article on:

Therapeutic Effects of Hepatocyte Transplantation on Hemophilia B

Tatsumi, Kohei1; Ohashi, Kazuo2,3,4,5; Shima, Midori1; Nakajima, Yoshiyuki2; Okano, Teruo3; Yoshioka, Akira1

doi: 10.1097/TP.0b013e31817b9160
Brief Reports

Hepatocyte transplantation offers an alternative therapeutic approach in the treatment of liver-related diseases. Hemophilia B is a bleeding disorder lacking factor IX (FIX) production in the liver, and achieving more than 1% coagulation activity results in significant improvement in the quality of life of the patients. The aim of this study was to investigate the efficacy of hepatocyte transplantation in the mouse model of hemophilia B. We transplanted isolated normal mouse hepatocytes into the liver of FIX knock-out mice. In some recipient mice, additional hepatocyte transplantations were performed 15 days after the first transplant. The recipient plasma FIX activities increased at 1% to 2% and persisted throughout the experimental period. An additional increase was achieved by the repeated transplantation. Close correlation between FIX messenger RNA levels of the liver and plasma FIX activity levels was observed. These results demonstrate that hepatocyte transplantation can provide therapeutic benefits in the treatment of hemophilia B.

1 Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.

2 Department of Surgery, Nara Medical University, Kashihara, Nara, Japan.

3 Institute of Advanced Biomedical Engineering and Science, Tokyo Women’s Medical University, Shinjuku-ku, Tokyo, Japan.

4 Department of Gastroenterological Surgery Tokyo Women’s Medical University, Tokyo, Japan.

This work was supported by grants form AIDS Research from the Ministry of Health, Labor and Welfare of Japan (A.Y.) and grant-in-Aid (18591957) (K.O.) and Special Coordination Funds for Promoting Science and Technology (K.O., T.O.), and from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.

5 Address correspondence to: Kazuo Ohashi, M.D., Ph.D., Institute of Advanced Biomedical Engineering and Science, Tokyo Women’s Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan.


Received 8 November 2007. Revision requested 11 December 2007.

Accepted 2 April 2008.

© 2008 Lippincott Williams & Wilkins, Inc.